Scientists have uncovered an enormous hidden archive of plant DNA that has endured for more than 400 million years. By comparing hundreds of plant genomes, researchers identified more than 2.3 million ...

In Michigan Tech's biology teaching lab, undergraduate students research potential cancer cures with help from the humble worm.

Have you ever questioned everything you thought you knew about the world? That moment when a single piece of information completely flips your understanding ...

INSTALL results showed successful and safe non-viral insertion of large genetic payloads in the livers of mice when delivered by lipid nanoparticles (LNPs). In contrast, mice experienced fatal immune ...

KOMO Biosciences, a developer of non-viral targeted insertion technologies, today announced that it has granted Syngenta, a world leader in agricultural innovation, a Research Evaluation License to ...

Experiments, robots and demonstrations filled the gym at Summit Academy Charter School in Red Hook, where students became teachers and scientists during a new day-long ...

The Free Software Foundation (FSF), a Massachusetts 501 (c) (3) charity with a worldwide mission to promote computer user freedom, seeks a motivated and talented individual to be our new Engineering ...

Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering genetic instructions that enable cells to produce ...

Stephen Hawking's black hole fame wasn't his only focus — he also laid out multiple existential threats. Here are five doomsday risks he talked about.

The Pershing Square Foundation today announced the eight winners of the "MIND" Prize (Maximizing Innovation in Neuroscience Discovery). Through the Prize, the Foundation strives to change the paradigm ...

Stylus Medicine, a member of BioSpace’s NextGen Class of 2026, launched in May 2025 to develop new, less complex genetic medicines. The company’s in vivo approach has attracted “intense” interest from ...

Scientists developed a new mRNA platform that keeps vaccines and therapies effective in older adults and patients with obesity, where current treatments often lose potency.